BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9039935)

  • 1. Adoptive immunotherapy in canine chimeras.
    Kolb HJ; Günther W; Schumm M; Holler E; Wilmanns W; Thierfelder S
    Transplantation; 1997 Feb; 63(3):430-6. PubMed ID: 9039935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
    Junghanss C; Takatu A; Little MT; Maciej Zaucha J; Zellmer E; Yunusov M; Sale G; Georges GE; Storb R
    Transplantation; 2003 Feb; 75(3):268-74. PubMed ID: 12589144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL; Atasoylu AA
    Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
    Georges GE; Storb R; Thompson JD; Yu C; Gooley T; Bruno B; Nash RA
    Blood; 2000 May; 95(10):3262-9. PubMed ID: 10807798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive immunotherapy with donor lymphocyte transfusions.
    Kolb HJ; Holler E
    Curr Opin Oncol; 1997 Mar; 9(2):139-45. PubMed ID: 9161791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.
    Schumm M; Günther W; Kolb HJ; Rieber P; Büttner M; Voss C; Kremmer E; Reitmeier P; Thierfelder S; Wilmanns W
    Tissue Antigens; 1994 Mar; 43(3):170-8. PubMed ID: 7522357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance.
    Weiden PL; Storb R; Tsoi MS; Graham TC; Lerner KG; Thomas ED
    J Immunol; 1976 May; 116(5):1212-9. PubMed ID: 774975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation.
    Bruno B; Nash RA; Wallace PM; Gass MJ; Thompson J; Storb R; McSweeney PA
    Transplantation; 1999 Aug; 68(3):338-44. PubMed ID: 10459536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune transfer studies in canine allogeneic marrow graft donor-recipient pairs.
    Grosse-Wilde H; Krumbacher K; Schüning F; Doxiadis I; Mahmoud HK; Emde C; Schmidt-Weinmar A; Schaefer UW
    Transplantation; 1986 Jul; 42(1):64-7. PubMed ID: 3523884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.
    Yang I; Weiss L; Abdul-Hai A; Kasir J; Reich S; Slavin S
    Cancer Res; 2005 Nov; 65(21):9735-40. PubMed ID: 16266994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.